UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

125I-labeled Anti-Epidermal Growth Factor Receptor-vIII Single-Chain Fv Exhibits Specific and High-Level Targeting of Glioma Xenografts

Clinical cancer research, 1999-06, Vol.5 (6), p.1539-1549

1999

Link zum Volltext

Verfügbarkeit prüfen

Aberrant Otx2 expression enhances migration and induces ectopic proliferation of hindbrain neuronal progenitor cells

PloS one, 2012-04, Vol.7 (4), p.e36211-e36211

2012

Link zum Volltext

Verfügbarkeit prüfen

Activity of irofulven (6-hydroxymethylacylfulvene) in the treatment of glioblastoma multiforme-derived xenografts in athymic mice

Cancer chemotherapy and pharmacology, 2001-11, Vol.48 (5), p.413-416

2001

Link zum Volltext

Verfügbarkeit prüfen

Affinity‐matured anti‐glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas

International journal of cancer, 2011-07, Vol.129 (1), p.111-121

2011

Link zum Volltext

Verfügbarkeit prüfen

Affinity-matured recombinant immunotoxin targeting gangliosides 3′-isoLM1 and 3′,6'-isoLD1 on malignant gliomas

mAbs, 2013-09, Vol.5 (5), p.748-762

2013

Link zum Volltext

Verfügbarkeit prüfen

Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro

Molecular and chemical neuropathology, 1994-02, Vol.21 (2-3), p.129-138

1994

Link zum Volltext

Verfügbarkeit prüfen

Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

Nuclear medicine and biology, 2010-10, Vol.37 (7), p.741-750

2010

Link zum Volltext

Verfügbarkeit prüfen

Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance

Nuclear medicine and biology, 2006, Vol.33 (1), p.101-110

2006

Link zum Volltext

Verfügbarkeit prüfen

Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

Nuclear medicine and biology, 2007-02, Vol.34 (2), p.173-183

2007

Link zum Volltext

Verfügbarkeit prüfen

Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis

Biological chemistry, 2009-02, Vol.390 (2), p.137-144

2009

Link zum Volltext

Verfügbarkeit prüfen

Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[ 211At]astato-3-pyridinecarboxylate

Nuclear medicine and biology, 1999-05, Vol.26 (4), p.405-411

1999

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma

Journal of neuroimmunology, 2000-02, Vol.103 (1), p.16-25

2000

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

The Journal of experimental medicine, 1997-10, Vol.186 (7), p.1177-1182

1997

Link zum Volltext

Verfügbarkeit prüfen

Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer Model

The Journal of biological chemistry, 2003-05, Vol.278 (18), p.15951-15957

2003

Link zum Volltext

Verfügbarkeit prüfen

Brain Tumors in Mice Are Susceptible to Blockade of Epidermal Growth Factor Receptor (EGFR) with the Oral, Specific, EGFR-Tyrosine Kinase Inhibitor ZD1839 (Iressa)

Clinical cancer research, 2002-11, Vol.8 (11), p.3496-3502

2002

Link zum Volltext

Verfügbarkeit prüfen

Busulfan therapy of central nervous system xenografts in athymic mice

Cancer chemotherapy and pharmacology, 1994, Vol.35 (2), p.127-131

1994

Link zum Volltext

Verfügbarkeit prüfen

Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts

Biochemical pharmacology, 1988-11, Vol.37 (22), p.4313-4317

1988

Link zum Volltext

Verfügbarkeit prüfen

Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors

Anti-cancer agents in medicinal chemistry, 2011-02, Vol.11 (2), p.202

2011

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft

Cancer chemotherapy and pharmacology, 1997, Vol.40 (5), p.409-414

1997

Link zum Volltext

Verfügbarkeit prüfen

Chimeric anti-tenascin antibody 81C6: Increased tumor localization compared with its murine parent

Nuclear medicine and biology, 1996-05, Vol.23 (4), p.449-458

1996

Link zum Volltext

Verfügbarkeit prüfen

Chromosomal composition of malignant human gliomas through serial subcutaneous transplantation in athymic mice

Cancer genetics and cytogenetics, 1989-07, Vol.40 (1), p.111-120

1989

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Molecular cancer therapeutics, 2005-01, Vol.4 (1), p.101-112

2005

Link zum Volltext

Verfügbarkeit prüfen

Design of a Novel Small Peptide Targeted against a Tumor-Specific Receptor

Biochemical and biophysical research communications, 2000-08, Vol.275 (2), p.631-636

2000

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a cell-based fluorescent method for measuring antibody affinity

Journal of immunological methods, 2017-03, Vol.442, p.49-53

2017

Link zum Volltext

Verfügbarkeit prüfen

Development of a model of melphalan-induced gastrointestinal toxicity in mice

Cancer chemotherapy and pharmacology, 1993, Vol.31 (5), p.376-380

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 126

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

Zeitschrift / SerieCancer Research

ThemaMice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(122)
Mit Volltextzugriff
(119)

Publikationsform

Artikel
(126)

Sprache

Englisch
(126)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

125I-labeled Anti-Epidermal Growth Factor Receptor-vIII Single-Chain Fv Exhibits Specific and High-Level Targeting of Glioma Xenografts

Aberrant Otx2 expression enhances migration and induces ectopic proliferation of hindbrain neuronal progenitor cells

Activity of irofulven (6-hydroxymethylacylfulvene) in the treatment of glioblastoma multiforme-derived xenografts in athymic mice

Affinity‐matured anti‐glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas

Affinity-matured recombinant immunotoxin targeting gangliosides 3′-isoLM1 and 3′,6'-isoLD1 on malignant gliomas

Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro

Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance

Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands

Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosis

Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[ 211At]astato-3-pyridinecarboxylate

Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer Model

Brain Tumors in Mice Are Susceptible to Blockade of Epidermal Growth Factor Receptor (EGFR) with the Oral, Specific, EGFR-Tyrosine Kinase Inhibitor ZD1839 (Iressa)

Busulfan therapy of central nervous system xenografts in athymic mice

Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts

Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors

Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft

Chimeric anti-tenascin antibody 81C6: Increased tumor localization compared with its murine parent

Chromosomal composition of malignant human gliomas through serial subcutaneous transplantation in athymic mice

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Design of a Novel Small Peptide Targeted against a Tumor-Specific Receptor

Development and validation of a cell-based fluorescent method for measuring antibody affinity

Development of a model of melphalan-induced gastrointestinal toxicity in mice

Aktive Filter

Suchergebnisse filtern